# A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis

> **NCT03987763** · PHASE4 · RECRUITING · sponsor: **Bausch Health Americas, Inc.** · enrollment: 45 (estimated)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** IDP-122 Lotion

## Key facts

- **NCT ID:** NCT03987763
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-10-22
- **Primary completion:** 2026-05
- **Final completion:** 2026-06
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2025-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03987763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03987763, "A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT03987763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*